EcoR1 Capital’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-212,365
Closed -$24.9M 67
2020
Q3
$41.9M Sell
212,365
-50,451
-19% -$12.7M 2.99% 12
2020
Q2
$73.5M Buy
262,816
+46,926
+22% +$10.9M 5.43% 6
2020
Q1
$38.4M Buy
215,890
+16,868
+8% +$3.62M 4.01% 10
2019
Q4
$48.9M Buy
199,022
+190,972
+2,372% +$35.2M 4.4% 8
2019
Q3
$950K Buy
+8,050
New +$1.22M 0.12% 35
2019
Q2
Sell
-96,133
Closed -$18.3M 42
2019
Q1
$22.7M Sell
96,133
-104,271
-52% -$26.4M 2.09% 16
2018
Q4
$54.4M Sell
200,404
-44,860
-18% -$13M 5.44% 5
2018
Q3
$109M Hold
245,264
9.85% 2
2018
Q2
$115M Hold
245,264
10.99% 3
2018
Q1
$145M Hold
245,264
14.51% 1
2017
Q4
$133M Hold
245,264
15% 1
2017
Q3
$103M Hold
245,264
13.7% 1
2017
Q2
$60.8M Hold
245,264
10.79% 3
2017
Q1
$75M Hold
245,264
18.97% 1
2016
Q4
$35.8M Hold
245,264
11.38% 3
2016
Q3
$21.2M Hold
245,264
6.51% 4
2016
Q2
$16.3M Buy
245,264
+70,405
+40% +$4.62M 6.44% 5
2016
Q1
$10.5M Hold
174,859
3.68% 10
2015
Q4
$15.8M Buy
174,859
+17,603
+11% +$1.92M 4.95% 7
2015
Q3
$18M Buy
157,256
+26,080
+20% +$4.59M 8.21% 6
2015
Q2
$30.3M Hold
131,176
10.11% 3
2015
Q1
$20.8M Buy
131,176
+47,030
+56% +$6.36M 6.95% 5
2014
Q4
$7.94M Buy
+84,146
New +$8.29M 4.02% 12

Other funds holding ASMB

EcoR1 Capital's ASMB Position: Q4 2020 in Review

EcoR1 Capital sold out of Assembly Biosciences (ASMB) in Q4 2020, closing a stake of 212,365 shares — an estimated $24.9M sold.

EcoR1 Capital first reported a position in ASMB in Q4 2014 and held it in 23 quarters. The position peaked at $145M in Q1 2018. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

  • EcoR1 Capital reported no remaining Assembly Biosciences position as of Q4 2020 after selling out during the quarter.
  • EcoR1 Capital sold 212,365 Assembly Biosciences shares in Q4 2020, an estimated $24.9M.
  • EcoR1 Capital first reported a position in Assembly Biosciences in Q4 2014 and held it in 23 quarters.
  • EcoR1 Capital's Assembly Biosciences position peaked at $145M in Q1 2018.
  • 109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on EcoR1 Capital's 13F filing for Q4 2020, filed 16 Feb 2021.